Contributors to white matter damage in Alzheimer's disease

Contributors to white matter damage in Alzheimer's disease

Bibliographic Details
Main Authors:	Chalmers, K, Wilcock, G, Love, S
Format:	Conference item
Published:	2005

Similar Items

Contributors to white matter damage in the frontal lobe in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
by: Williams, S, et al.
Published: (2005)

Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease.
by: Williams, S, et al.
Published: (2005)

APOE epsilon 4 favours vascular over parenchymal deposition of A beta protein in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2002)

APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein.
by: Chalmers, K, et al.
Published: (2003)

The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease
by: Chalmers, K, et al.
Published: (2004)

Distinct contribution of white matter damage to the clinical syndrome of Alzheimer's disease
by: Coutu, Jean-Philippe
Published: (2016)

Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia.
by: Barker, R, et al.
Published: (2014)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
by: Qing Wang, et al.
Published: (2019-01-01)

The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.
by: Amar, K, et al.
Published: (1996)

APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2004)

Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
by: Chalmers, K, et al.
Published: (2009)

Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy.
by: Miners, J, et al.
Published: (2006)

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease.
by: Baig, S, et al.
Published: (2005)

Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
by: Chalmers, K, et al.
Published: (2008)

Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy
by: Miners, J, et al.
Published: (2006)

No correlation between nigral degeneration and striatal plaques in Alzheimer's disease.
by: Love, S, et al.
Published: (1996)

Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology
by: Baig, S, et al.
Published: (2004)

Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer's disease.
by: Laurence O'Dwyer, et al.
Published: (2011-01-01)

White matter connectivity for detection of Alzheimer's disease
by: Huang, Dajing
Published: (2017)

Degradation of perineuronal nets surrounding parvalbumin-positive neurones in Alzheimer's disease
by: Baig, S, et al.
Published: (2005)

Matrix metalloproteinases 3 and 9 and loss of perineuronal nets in Alzheimer's disease
by: Baig, S, et al.
Published: (2006)

Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease.
by: van Helmond, Z, et al.
Published: (2007)

Independent component analysis-based identification of covariance patterns of microstructural white matter damage in Alzheimer's disease.
by: Xin Ouyang, et al.
Published: (2015-01-01)

Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease.
by: Love, S, et al.
Published: (1999)

White matter tract integrity in aging and Alzheimer's disease.
by: Damoiseaux, J, et al.
Published: (2009)

GERIATRIC DEPRESSION AND WHITE MATTER HYPERINTENSITIES IN ALZHEIMER`S DISEASE
by: Moon-Doo Kim, et al.
Published: (2023-10-01)

White Matter Network Alterations in Alzheimer’s Disease Patients
by: Ramesh Kumar Lama, et al.
Published: (2020-01-01)

Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease (vol 110, pg 393, 2005)
by: Baig, S, et al.
Published: (2006)

Degradation of perineuronal net around parvalbumin-positive neurons in Alzheimer's disease: Possible involvement of matrix metalloproteases.
by: Love, S, et al.
Published: (2005)

MMP-3 and-9 may degrade the perineuronal net but their activity is not increased in frontal cortex in Alzheimer's disease
by: Baig, S, et al.
Published: (2006)

Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.
by: Hansen, L, et al.
Published: (1998)

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins
by: Barker, R, et al.
Published: (2013)

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins.
by: Barker, R, et al.
Published: (2013)

Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins
by: Barker, R, et al.
Published: (2013)

White matter damage is associated with matrix metalloproteinases in Binswanger's disease
by: Rosenberg, G, et al.
Published: (2001)

White matter damage and systemic inflammation in Parkinson’s disease
by: Pi-Ling Chiang, et al.
Published: (2017-06-01)

White Matter and Neuroprotection in Alzheimer’s Dementia
by: Luca Lorenzini, et al.
Published: (2020-01-01)

Classification of Alzheimer’s Disease Based on White Matter Connectivity Network
by: Xiaoli Yang, et al.
Published: (2023-11-01)

Effects of Homocysteine on white matter diffusion parameters in Alzheimer’s disease
by: Chen-Chang Lee, et al.
Published: (2017-10-01)